Notis-McConarty Edward’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Buy |
18,950
+14,540
| +330% | +$1M | 0.64% | 38 |
|
|
2025
Q1 | $306K | Buy |
+4,410
| New | +$306K | 0.16% | 61 |
|
|
2024
Q4 | – | Sell |
-2,300
| Closed | -$274K | – | 85 |
|
|
2024
Q3 | $274K | Sell |
2,300
-300
| -12% | -$35.7K | 0.12% | 77 |
|
|
2024
Q2 | $371K | Sell |
2,600
-400
| -13% | -$57.1K | 0.15% | 72 |
|
|
2024
Q1 | $385K | Sell |
3,000
-320
| -10% | -$41.1K | 0.15% | 74 |
|
|
2023
Q4 | $343K | Sell |
3,320
-180
| -5% | -$18.6K | 0.14% | 76 |
|
|
2023
Q3 | $318K | Sell |
3,500
-300
| -8% | -$27.3K | 0.13% | 81 |
|
|
2023
Q2 | $307K | Sell |
3,800
-200
| -5% | -$16.2K | 0.12% | 83 |
|
|
2023
Q1 | $318K | Hold |
4,000
| – | – | 0.13% | 83 |
|
|
2022
Q4 | $271K | Sell |
4,000
-400
| -9% | -$27.1K | 0.11% | 89 |
|
|
2022
Q3 | $219K | Hold |
4,400
| – | – | 0.1% | 93 |
|
|
2022
Q2 | $245K | Sell |
4,400
-400
| -8% | -$22.3K | 0.1% | 92 |
|
|
2022
Q1 | $267K | Hold |
4,800
| – | – | 0.1% | 97 |
|
|
2021
Q4 | $269K | Sell |
4,800
-200
| -4% | -$11.2K | 0.09% | 95 |
|
|
2021
Q3 | $240K | Buy |
+5,000
| New | +$240K | 0.09% | 96 |
|
|
2015
Q4 | – | Sell |
-6,000
| Closed | -$163K | – | 106 |
|
|
2015
Q3 | $163K | Hold |
6,000
| – | – | 0.12% | 102 |
|
|
2015
Q2 | $164K | Buy |
6,000
+1,000
| +20% | +$27.3K | 0.11% | 109 |
|
|
2015
Q1 | $133K | Hold |
5,000
| – | – | 0.09% | 111 |
|
|
2014
Q4 | $106K | Hold |
5,000
| – | – | 0.07% | 114 |
|
|
2014
Q3 | $119K | Hold |
5,000
| – | – | 0.08% | 113 |
|
|
2014
Q2 | $115K | Hold |
5,000
| – | – | 0.08% | 108 |
|
|
2014
Q1 | $114K | Buy |
5,000
+1,000
| +25% | +$22.8K | 0.08% | 100 |
|
|
2013
Q4 | $74K | Buy |
+4,000
| New | +$74K | 0.05% | 106 |
|